EUVIMEDSkopri EUVIMED
Beobachtungsstudie

Artificial Intelligence Analysis of Standard 12‐Lead Electrocardiograms for Screening of Symptomatic Diabetic Peripheral Neuropathy

Paweł Ignacy iD, Hanadi Aldosari, Krzysztof Irlik, Martyna Gut-Misiaga, Aleksandra Gil, Hanna Kwiendacz, Janusz Gumprecht, Gregory Y H Lip iD, Uazman Alam iD, Katarzyna Nabrdalik iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71240 ↗

At a glance

Beobachtungsstudie in Diabetes, Obesity and Metabolism, 2026. Written by Paweł Ignacy and 9 co-authors. Institution: Doctoral School, Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, K…. Major MEDLINE topics: Diabetic Neuropathies, Electrocardiography, Artificial Intelligence, Mass Screening. 36 references. Funded by: Medical University of Silesia in Katowice.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aim

To investigate whether artificial intelligence (AI) models trained on standard 12‐lead electrocardiograms (ECG) can identify symptom‐defined diabetic peripheral neuropathy (DPN) as assessed by the Michigan Neuropathy Screening Instrument Questionnaire (MNSI‐Q). Materials This was an observational study of people with diabetes enrolled in the Silesia‐Diabetes Heart Project. DPN was assessed using the MNSI‐Q. We used an original questionnaire cut‐off score of ≥ 7 and revised cut‐off score of ≥ 4 to diagnose DPN and classified DPN as highly symptomatic and moderately symptomatic accordingly. Feature extraction from 10‐s raw ECG recordings utilised algorithms to identify recurring signal segments (motifs) and anomalies (discords). These features were used to train XGBoost, Support Vector Machine (SVM) and Ridge classifiers to differentiate between DPN‐positive and DPN‐negative people.

Results

A total of 640 participants (mean age 54 ± 17; 52% female) were included. Of these, 95 (15%) had highly symptomatic DPN (MNSI‐Q ≥ 7) and 281 (44%) had moderately symptomatic DPN (MNSI‐Q ≥ 4). For the highly symptomatic DPN, the XGBoost classifier utilizing a combination of motifs and discords demonstrated the highest performance, achieving an area under the receiver‐operating characteristic curve (AUC) of 0.89 (95% CI 0.88–0.91), an accuracy of 88.5% and a sensitivity of 93.4%. The model showed substantially lower predictive capability when tested against the broader screening threshold of MNSI ≥ 4 (AUC 0.64).

Conclusion

AI analysis of the standard ECG demonstrated a strong association with the presence of symptom‐defined peripheral neuropathy but lacked sensitivity for milder presentation. With further validation, this method could serve as an accessible, supplementary screening aid to help identify high‐risk patients during routine cardiovascular assessment.

Subjects

MeSH terms (MEDLINE)

Diabetic NeuropathiesElectrocardiographyArtificial IntelligenceMass ScreeningHumansFemaleMaleMiddle AgedAgedAdultSurveys and QuestionnairesSensitivity and SpecificityBoosting Machine Learning AlgorithmsSupport Vector Machine

Author keywords

Michigan neuropathy screening instrumentartificial intelligencediabetic peripheral neuropathyelectrocardiographymachine learning

Authors and institutions

  • Doctoral School, Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.
  • Department of Artificial Intelligence and Data Science, College of Computer Science and Engineering, Taibah University, Madinah, Saudi Arabia.
  • Student's Scientific Association at the Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

ORCID profiles: Paweł Ignacy, Gregory Y H Lip, Uazman Alam, Katarzyna Nabrdalik

Funding

  • Medical University of Silesia in Katowice

Cite

APA

Ignacy, P., Aldosari, H., Irlik, K., Gut-Misiaga, M., Gil, A., Kwiendacz, H., Gumprecht, J., Lip, G. Y. H., Alam, U., & Nabrdalik, K. (2026). Artificial Intelligence Analysis of Standard 12‐Lead Electrocardiograms for Screening of Symptomatic Diabetic Peripheral Neuropathy. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71240

Vancouver

Ignacy P, Aldosari H, Irlik K, Gut-Misiaga M, Gil A, Kwiendacz H, et al. Artificial Intelligence Analysis of Standard 12‐Lead Electrocardiograms for Screening of Symptomatic Diabetic Peripheral Neuropathy. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71240

BibTeX
@article{Ignacy2026,
  author = {Ignacy, Paweł and Aldosari, Hanadi and Irlik, Krzysztof and Gut-Misiaga, Martyna and Gil, Aleksandra and Kwiendacz, Hanna and Gumprecht, Janusz and Lip, Gregory Y H and Alam, Uazman and Nabrdalik, Katarzyna},
  title = {Artificial Intelligence Analysis of Standard 12‐Lead Electrocardiograms for Screening of Symptomatic Diabetic Peripheral Neuropathy},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71240}
}
Start for free →